1. Home
  2. AVR vs EUDA Comparison

AVR vs EUDA Comparison

Compare AVR & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVR
  • EUDA
  • Stock Information
  • Founded
  • AVR 1999
  • EUDA 2021
  • Country
  • AVR Australia
  • EUDA Singapore
  • Employees
  • AVR N/A
  • EUDA N/A
  • Industry
  • AVR
  • EUDA Blank Checks
  • Sector
  • AVR
  • EUDA Finance
  • Exchange
  • AVR NYSE
  • EUDA Nasdaq
  • Market Cap
  • AVR 162.1M
  • EUDA 146.0M
  • IPO Year
  • AVR 2024
  • EUDA N/A
  • Fundamental
  • Price
  • AVR $3.36
  • EUDA $3.18
  • Analyst Decision
  • AVR Strong Buy
  • EUDA
  • Analyst Count
  • AVR 4
  • EUDA 0
  • Target Price
  • AVR $16.50
  • EUDA N/A
  • AVG Volume (30 Days)
  • AVR 315.5K
  • EUDA 93.4K
  • Earning Date
  • AVR 08-16-2025
  • EUDA 01-01-0001
  • Dividend Yield
  • AVR N/A
  • EUDA N/A
  • EPS Growth
  • AVR N/A
  • EUDA N/A
  • EPS
  • AVR N/A
  • EUDA N/A
  • Revenue
  • AVR $2,493,000.00
  • EUDA $4,011,005.00
  • Revenue This Year
  • AVR $25.79
  • EUDA $212.19
  • Revenue Next Year
  • AVR $211.91
  • EUDA $254.35
  • P/E Ratio
  • AVR N/A
  • EUDA N/A
  • Revenue Growth
  • AVR N/A
  • EUDA 8.22
  • 52 Week Low
  • AVR $2.34
  • EUDA $2.92
  • 52 Week High
  • AVR $8.79
  • EUDA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • AVR N/A
  • EUDA 41.59
  • Support Level
  • AVR N/A
  • EUDA $3.35
  • Resistance Level
  • AVR N/A
  • EUDA $3.60
  • Average True Range (ATR)
  • AVR 0.00
  • EUDA 0.15
  • MACD
  • AVR 0.00
  • EUDA -0.02
  • Stochastic Oscillator
  • AVR 0.00
  • EUDA 0.00

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.

Share on Social Networks: